Metraipolis › archive › dc_7ffad2374685

Individualizing Injectable Testosterone Replacement Therapy in Primary Care: Pharmacokinetics, Symptom Stability, Safety Monitoring, and Injection Frequency — Europe PMC PMID:42292725

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292725
DOI
10.7759/cureus.110570
License (as archived)
solo-consultazione
Archived
2026-10-31T15:23:23.114Z
SHA-256 of the archived text
e60f0d0f2337af0b28c1e97767751c19e69b0bf815592f37fed19a17c8bed24a
Stable URL of this page
https://metraipolis.com/documento/dc_7ffad2374685

How to cite

Individualizing Injectable Testosterone Replacement Therapy in Primary Care: Pharmacokinetics, Symptom Stability, Safety Monitoring, and Injection Frequency — Europe PMC PMID:42292725 — Europe PMC (en), https://europepmc.org/article/MED/42292725 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ffad2374685 (Metraipolis archive dc_7ffad2374685, sha256 e60f0d0f2337af0b28c1e97767751c19e69b0bf815592f37fed19a17c8bed24a)
BibTeX
@misc{dc7ffad2374685,
  title = {Individualizing Injectable Testosterone Replacement Therapy in Primary Care: Pharmacokinetics, Symptom Stability, Safety Monitoring, and Injection Frequency — Europe PMC PMID:42292725},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292725},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ffad2374685; sha256 e60f0d0f2337af0b28c1e97767751c19e69b0bf815592f37fed19a17c8bed24a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292725. Agents can read the archived copy with the MCP tool read_document.